KUALA LUMPUR, Malaysia, Oct 5 (Bernama) — Universal Therapeutics, a multinational pharmaceutical and biotech company based in Malaysia, today announced that the Medical Device Authority of Malaysia (MDA) has approved the SARS-CoV-2 Antigen Rapid Test Kit (Saliva) for self-testing.
Manufactured by Triplex International Biosciences (China), the easy-to-use Rapid Test Kit can quickly detect the possibility of a COVID-19 infection, with a sensitivity of 100% specificity of 100% and accuracy of 100%. The test kit works by detecting the presence of the coronavirus nucleocapsid protein in saliva samples. Infants under the age of two are not recommended to use this test kit.
